Last updated on May 2017

Focal MR-Guided Focused Ultrasound Treatment of Localized Intermediate Risk Prostate Cancer


Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Prostate Cancer
  • Age: 50 Years
  • Gender: Male

  • Males age 50 and older
  • Biopsy proven adenocarcinoma of the prostate.
  • Patient with intermediate risk, early-stage organ-confined prostate cancer and voluntarily chooses ExAblate thermal ablation as the non-invasive treatment, who may currently be on watchful waiting or active surveillance and not in need of imminent radical therapy.

  • Recruitment Status: Open


    Brief Description Eligibility Contact Research Team


    Receive Emails About New Clinical Trials!

    Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.